FDA Import Refusal 1FX-2233101-0/10002/1 — Lifevision Healthcare
The FDA refused shipment 1FX-2233101-0/10002/1 from Lifevision Healthcare (India) on Apr 7, 2026. The refused product falls under Drugs and Biologics — TELMISARTAN (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Apr 7, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62ODA09 TELMISARTAN (ANTI-HYPERTENSIVE - PART II)
- Charges
- 75